Ryosuke Kumanishi
Yamagata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
SMARCB1/INI1-deficient Undifferentiated Carcinoma Presenting as Cancer of Unknown Primary with Massive Hepatic Involvement: Transient Response to FOLFOX plus Nivolumab.
Journal: Internal medicine (Tokyo, Japan)
Published: August 10, 2026
Genomic Landscape and Therapeutic Implications of Metaplastic Breast Carcinoma: Insights from a Nationwide Database Including Diagnostic Mimickers.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 18, 2026
Clinical Implications of Coexisting EWSR1 Rearrangements in Ewing Sarcoma: A Database Analysis and Representative Cases.
Journal: Internal medicine (Tokyo, Japan)
Published: November 12, 2025
Serum HER2 extracellular domain as a predictive biomarker for trastuzumab deruxtecan treatment response in HER2-positive gastric cancer: a real-world study.
Journal: Therapeutic advances in gastroenterology
Published: August 25, 2025
Potential Resistance to Oxaliplatin-Based Regimens in Gastric Cancer Patients with ERBB2 R678Q Mutation: Evidence from a National Genomic Database.
Journal: Current issues in molecular biology
Published: May 04, 2025
Pancreatic Mixed Acinar-neuroendocrine Carcinoma in a Patient With a Germline PTEN Variant: A Case Report and Genomic Literature Review.
Journal: In vivo (Athens, Greece)
Published: December 27, 2024
Limited Efficacy of Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients with Rare RAS Variants: Analysis of the C-CAT Database.
Journal: Current issues in molecular biology
Published: November 30, 2024
Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5-Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study.
Journal: Cancer medicine
Published: July 05, 2024
Ⅰ. Current and Future Immunotherapy for MSI-H Unresectable or Recurrent Colorectal Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 06, 2023
Chronological improvement of survival in patients with advanced gastric cancer over 15 years.
Journal: Therapeutic advances in medical oncology
Published: September 10, 2023
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).
Journal: The oncologist
Published: July 15, 2023
Differential Efficacy of Targeted Monoclonal Antibodies in Left-Sided Colon and Rectal Metastatic Cancers.
Journal: Clinical colorectal cancer
Published: March 05, 2023
Last Updated: 09/26/2026